Keywords: Head & Neck/ENT, Cancer, Head and Neck Cancer, T1rho mapping, T2 mapping, Radiotherapy, Treatment responses
Motivation: Early assessment of response to radiotherapy may be useful to crucial for effectively managing head and neck cancer (HNC).
Goal(s): To evaluate the response to radiotherapy in HNC using quantitative 3D T1rho and T2 mapping.
Approach: T1rho and T2 mapping was performed on a healthy volunteer and three HNC patients, one of whom was scanned before, during, and after radiotherapy.
Results: Significant decrease in T1rho and T2 values of the tumor were observed two weeks after starting and completing radiotherapy. However, the values in other tissues, such as muscles, remained relatively stable across the three scans.
Impact: This study evaluates the feasibility of using quantitative T1rho and T2 mapping to assess the treatment response to radiotherapy for head and neck cancer. This information could be valuable in tailoring individualized treatments for patients with head and neck cancer.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords